Maintenance of tracheal tube cuff pressure: where are the limits? by Ferrer, Miquel & Torres, Antoni
Page 1 of 2
(page number not for citation purposes)
Available online http://ccforum.com/content/12/1/106
Abstract
Continuous control of tracheal tube cuff inflation using a pneumatic
device resulted in severe tracheal wall damage in ventilated piglets.
This damage was similar in piglets managed with manual control of
cuff inflation. The periodic hyperinflation of the tube cuff used in
both groups of this study may explain these results. This manoeuvre
should be avoided in clinical practice.
In a previous issue of Critical Care, Nseir and colleagues
presented an article regarding continuous control of endo-
tracheal cuff pressure and tracheal wall damage [1].
Among the pathogenic mechanisms responsible for venti-
lator-associated pneumonia (VAP), oropharyngeal coloniza-
tion by potentially pathogenic microorganisms and silent
aspiration of subglottic secretions around the tracheal tube
cuff seem to play a pivotal role [2]. In order to prevent
pneumonia, several approaches have been proposed – such
as placing patients in the semirecumbent position [3],
continuous aspiration of subglottic secretions (CASS) above
the tracheal tube cuff [4], oropharyngeal decontamination by
antiseptics [5], and the application of antiseptic-impregnated
endotracheal tubes [6].
The key element of the proposed pathogenesis of VAP
appears to be aspiration of colonized oropharyngeal and
subglottic secretions. Appropriate control of the endotracheal
tube cuff pressure (Pcuff) may therefore serve as a major
prevention target. Intubated patients were recommended to
be managed with Pcuff values between 20 and 30  cmH2O to
provide a sufficient seal without compromising mucosal
perfusion [7]. The routine management of cuff inflation
consists of periodic manual checking of the Pcuff, which does
not ensure the appropriate maintenance of the Pcuff during
continuous tracheal intubation [8]. Moreover, the manual
checking of the Pcuff may cause either overinflation or defla-
tion of the cuff and may cause aspiration of contaminated
secretions to the lower airway during the manoeuvre. Leaks
and loss of Pcuff are frequent in intubated patients, and a
persistent  Pcuff below 20 cmH2O was an independent risk
factor for VAP in one study [8]. Consequently, appropriate
maintenance of pressure of the tracheal tube cuff is
recommended in recent guidelines [9].
In a previous issue of the journal, Nseir and coworkers
describe a pneumatic device for the continuous control of the
Pcuff in an animal model [1]. The aim of the study was to
assess whether the continuous control of the Pcuff results in
reduced tracheal ischaemic lesions in mechanically ventilated
piglets. For this purpose, the authors compared the
pneumatic device with the manual control of Pcuff in a
randomized trial. The pneumatic device provided effective
continuous control of the Pcuff, with longer periods of Pcuff
within the target values than piglets managed with manual
control. This device is therefore potentially useful for clinical
practice in order to avoid both excessive inflation and
deflation of the cuff. Hyperaemia and haemorrhages in the
trachea were observed at the cuff contact area in all animals,
however, with no differences between animals with and
without the pneumatic device.
Several devices that provide an automatic and continuous
effective control of the Pcuff have been described in the
literature. Most of these devices are not automatic, some
devices need frequent control by the attending staff, and
other devices operating in a more automatic and continuous
way are complex, requiring the use of special and expensive
equipment that may not be available routinely [10]. It is
probable that these issues concerning complexity and cost
could explain the lack of continuous automatic control of cuff
inflation inclinical practice.
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We have described a simple and cheap device that is very
effective for the routine maintenance of adequatecuff inflation
during mechanical ventilation that does not require any
specific equipment [11]. A recent randomized clinical trial in
mechanically ventilated patients comparing this device with
the routine manual control of cuff inflation, however, showed
no benefits in the prevention of VAP [12]. These findings
suggest that other factors than cuff inflation influence the
microaspiration of secretions to the lower airways around the
tracheal tube cuff. Commercially available high-volume low-
pressure tracheal tubes such as those used in the study often
form folds around the cuff, hence allowing leakage of
secretions pooled above the tube cuff in studies in vitro, even
at Pcuff levels similar to those used by Nseir and colleagues in
piglets [13]. Several devices have consequently been
recently developed in order to overcome this problem.
Among those devices, the Microcuff endotracheal high-
volume low-pressure tube features an ultrathin (7 μm) poly-
urethane cuff membrane around an inner conventional
inflatable cuff. This tube is effective in preventing fluid leakage
around the cuff in an in vitro setup [14]. The combination of
this device with CASS is effective in preventing both early-
onset and late-onset VAP in a recent clinical study [15].
One of the potential concerns of all these devices, particularly
CASS, is the potential damage of the tracheal wall. In an
animal sheep model, Berra and colleagues demonstrated
important tracheal lesions when using CASS [16]. We do not
know whether this is applicable to humans. In the study by
Nseir and colleagues, the tracheal lesions found could be
explained, at least in part, by the high inflation pressure they
applied eight times daily via 50 ml during 30 min. This is not
the current clinical practice in humans, and after this study it
should be completely avoided.
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